Terbutaline and Associated Risks for Neurodevelopmental Disorders

about

Terbutaline and Associated Risks for Neurodevelopmental Disorders

Item

http://www.wikidata.org/entity/Q59035957

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2014

@uk

name

Terbutaline and Associated Risks for Neurodevelopmental Disorders

@en

Terbutaline and Associated Risks for Neurodevelopmental Disorders

@nl

type

Item

label

Terbutaline and Associated Risks for Neurodevelopmental Disorders

@en

Terbutaline and Associated Risks for Neurodevelopmental Disorders

@nl

prefLabel

Terbutaline and Associated Risks for Neurodevelopmental Disorders

@en

Terbutaline and Associated Risks for Neurodevelopmental Disorders

@nl

P1476

Terbutaline and Associated Risks for Neurodevelopmental Disorders

@en

P2093

Ashlee Loughan

http://www.w3.org/2001/XMLSchema#string

Hana Perkey

http://www.w3.org/2001/XMLSchema#string

Kelly Tyson

http://www.w3.org/2001/XMLSchema#string

Robert Perna

http://www.w3.org/2001/XMLSchema#string

P2860

Terbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomes

Developmental exposure to terbutaline and chlorpyrifos, separately or sequentially, elicits presynaptic serotonergic hyperactivity in juvenile and adolescent rats

beta2-adrenergic receptor activation and genetic polymorphisms in autism: data from dizygotic twins.

Efficacy of maintenance therapy after acute tocolysis: a meta-analysis.

Effectiveness of terbutaline pump for the prevention of preterm birth. A systematic review and meta-analysis.

Perinatal care at the threshold of viability.

The management of preterm labor.

Prenatal exposure to β2-adrenergic receptor agonists and risk of autism spectrum disorders

Cumulative high doses of inhaled formoterol have less systemic effects in asthmatic children 6-11 years-old than cumulative high doses of inhaled terbutaline

In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes.

P304

1-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/358608

http://www.w3.org/2001/XMLSchema#string

P478

2014

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

neurodevelopmental disorders